Process R&D

Process R&D

Process development

PharmaResources adheres to the Quality by Design (QbD) philosophy toprovide customers one-stop efficient solutions through synthetic route design and screening, process optimization, scale-up, validation and process safety assessment, and thus improve customers’ R&D efficiency and shorten the drug development cycle. The innovative drug process development services provided by the company cover the entire process from preclinical studies to new drug launch.

Services include:

  • Our new drug process development services have broken through known synthetic pathways or pioneering innovative synthetic process routes to achieve customized optimization from preclinical to new drug market launch.
  • We conduct research and define key process parameters to support scale-up, process validation, and commercial manufacturing .for cGMP or non-cGMP manufacturing
PharmaResources is committed to discovering and developing innovative synthetic processes, by establishment of platforms such as flow chemistry, enzymatic catalysis, asymmetric catalysis, solid-state chemistry and safety assessment. These platforms support process R&D and optimization, quality research, and help clients achieve low-cost, safe, green, and reliable commercial manufacturing of intermediates and APIs from kilograms to tons.
  • Address

    Bldg. 12, No. 59 Kai Qing Rd, Pudong, Shanghai (West Campus)

    Bldg. 7, No. 509 Ren Qing Rd, Pudong, Shanghai (East Campus)

  • Investment Contact


  • Email

    Will reply as soon as possible.

Copyright © Copyright 2024 PharmaResources (Shanghai) Co., Ltd. (Official Website)

Reference No: Shanghai ICP 20013779 Website Constructed by:Ocean Design, Shanghai